Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Emerging concepts in pseudoenzyme classification, evolution, and signaling.

Ribeiro AJM, Das S, Dawson N, Zaru R, Orchard S, Thornton JM, Orengo C, Zeqiraj E, Murphy JM, Eyers PA.

Sci Signal. 2019 Aug 13;12(594). pii: eaat9797. doi: 10.1126/scisignal.aat9797. Review.

PMID:
31409758
2.

From the research laboratory to the database: the Caenorhabditis elegans kinome in UniProtKB.

Zaru R, Magrane M, O'Donovan C; UniProt Consortium.

Biochem J. 2017 Feb 15;474(4):493-515. doi: 10.1042/BCJ20160991. Review.

3.

An update on the Enzyme Portal: an integrative approach for exploring enzyme knowledge.

Pundir S, Onwubiko J, Zaru R, Rosanoff S, Antunes R, Bingley M, Watkins X, O'Donovan C, Martin MJ.

Protein Eng Des Sel. 2017 Mar 1;30(3):245-251. doi: 10.1093/protein/gzx008.

4.

The PDK1-Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning.

Zaru R, Matthews SP, Edgar AJ, Prescott AR, Gomez-Nicola D, Hanauer A, Watts C.

J Immunol. 2015 Nov 1;195(9):4264-72. doi: 10.4049/jimmunol.1501520. Epub 2015 Sep 23.

5.

Structural and functional basis for p38-MK2-activated Rsk signaling in toll-like receptor-stimulated dendritic cells.

Zaru R, Edgar AJ, Hanauer A, Watts C.

Mol Cell Biol. 2015 Jan;35(1):132-40. doi: 10.1128/MCB.00773-14. Epub 2014 Oct 20.

6.

A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870.

Edgar AJ, Trost M, Watts C, Zaru R.

Biosci Rep. 2014 Feb 1;34(1). pii: e00091. Print 2014 Feb 1.

7.

TLR signalling regulated antigen presentation in dendritic cells.

Watts C, West MA, Zaru R.

Curr Opin Immunol. 2010 Feb;22(1):124-30. doi: 10.1016/j.coi.2009.12.005. Epub 2010 Jan 18. Review.

PMID:
20083398
8.

A role for ARF6 in dendritic cell podosome formation and migration.

Svensson HG, West MA, Mollahan P, Prescott AR, Zaru R, Watts C.

Eur J Immunol. 2008 Mar;38(3):818-28. doi: 10.1002/eji.200737331.

9.
10.

The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways.

Zaru R, Ronkina N, Gaestel M, Arthur JS, Watts C.

Nat Immunol. 2007 Nov;8(11):1227-35. Epub 2007 Sep 30. Erratum in: Nat Immunol. 2008 Jan;9(1):105.

PMID:
17906627
11.

CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse.

Espagnolle N, Depoil D, Zaru R, Demeur C, Champagne E, Guiraud M, Valitutti S.

Int Immunol. 2007 Mar;19(3):239-48. Epub 2007 Jan 12.

PMID:
17220479
12.

Proximal effects of Toll-like receptor activation in dendritic cells.

Watts C, Zaru R, Prescott AR, Wallin RP, West MA.

Curr Opin Immunol. 2007 Feb;19(1):73-8. Epub 2006 Dec 4. Review.

PMID:
17142025
13.

Immunological synapses are versatile structures enabling selective T cell polarization.

Depoil D, Zaru R, Guiraud M, Chauveau A, Harriague J, Bismuth G, Utzny C, Müller S, Valitutti S.

Immunity. 2005 Feb;22(2):185-94.

14.

Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling.

West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, Ljunggren HG, Prescott AR, Watts C.

Science. 2004 Aug 20;305(5687):1153-7.

15.

Cutting edge: T lymphocyte activation by repeated immunological synapse formation and intermittent signaling.

Faroudi M, Zaru R, Paulet P, Müller S, Valitutti S.

J Immunol. 2003 Aug 1;171(3):1128-32.

16.

New insights to the functional role of the T cell-antigen presenting cell immunological synapse.

Faroudi M, Zaru R, Favier B, Valitutti S.

Biol Res. 2002;35(2):133-7. Review.

PMID:
12415730
17.

Cutting edge: TCR engagement and triggering in the absence of large-scale molecular segregation at the T cell-APC contact site.

Zaru R, Cameron TO, Stern LJ, Müller S, Valitutti S.

J Immunol. 2002 May 1;168(9):4287-91.

18.

CD28 co-stimulates TCR/CD3-induced phosphoinositide turnover in human T lymphocytes.

Zaru R, Berrie CP, Iurisci C, Corda D, Valitutti S.

Eur J Immunol. 2001 Aug;31(8):2438-47.

19.

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.

Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J.

Nat Immunol. 2000 Dec;1(6):489-95.

PMID:
11101870
20.

Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes.

Leupin O, Zaru R, Laroche T, Müller S, Valitutti S.

Curr Biol. 2000 Mar 9;10(5):277-80.

Supplemental Content

Support Center